<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl3">
 <label>Table 3</label>
 <caption>
  <p>Adverse events</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th/>
    <th align="left">
     <bold>Grade 1â€“2</bold>
    </th>
    <th align="left">
     <bold>Grade 3</bold>
    </th>
    <th align="left">
     <bold>Grade 4</bold>
    </th>
    <th align="left">
     <bold>Grade 5</bold>
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left">Neutropenia</td>
    <td align="left">2 (3%)</td>
    <td align="left">5 (7%)</td>
    <td align="left">41 (55%)</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">Anaemia</td>
    <td align="left">8 (11%)</td>
    <td align="left">22 (29%)</td>
    <td align="left">4 (5%)</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">Thrombocytopenia</td>
    <td align="left">2 (3%)</td>
    <td align="left">1 (1%)</td>
    <td align="left">44 (59%)</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">Infections</td>
    <td align="left">17 (23%)</td>
    <td align="left">14 (19%)</td>
    <td align="left">8 (11%)</td>
    <td align="left">4 (5%)</td>
   </tr>
   <tr>
    <td align="left">Hepatotoxicity</td>
    <td align="left">8 (11%)</td>
    <td align="left">13 (17%)</td>
    <td align="left">0</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">Nephrotoxicity</td>
    <td align="left">7 (9%)</td>
    <td align="left">0</td>
    <td align="left">1 (1%)</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">Mucositis</td>
    <td align="left">8 (11%)</td>
    <td align="left">3 (4%)</td>
    <td align="left">1 (1%)</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">Nausea, vomiting, or diarrhoea</td>
    <td align="left">17 (23%)</td>
    <td align="left">3 (4%)</td>
    <td align="left">0</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">Central and peripheral neurotoxicity</td>
    <td align="left">10 (13%)</td>
    <td align="left">3 (4%)</td>
    <td align="left">0</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">Cardiotoxicity</td>
    <td align="left">2 (3%)</td>
    <td align="left">1 (1%)</td>
    <td align="left">0</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">Vascular events
     <xref rid="tbl3fn1" ref-type="table-fn">*</xref>
    </td>
    <td align="left">2 (3%)</td>
    <td align="left">1 (1%)</td>
    <td align="left">1 (1%)</td>
    <td align="left">0</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>Grade 1 or 2 adverse events are reported if occurring in at least 10% of patients in the treated population (n=75). In patients with multiple concomitant toxicities, each side-effect was considered and reported in the table separately.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl3fn1">
   <label>*</label>
   <p id="cenpara50">Deep vein thrombosis, pulmonary thromboembolism, or stroke.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
